Wednesday, 13th September
16:00 – 18:10 | Pick up documentation
what we could expect in the next years.
18:10 – 18:30 Welcome and presentation.
Julià Panés, Barcelona (Spain)
Raanan Shamir, Petach Tikva (Israel)
Dan Turner, Jerusalem (Israel)
Javier Martín de Carpi, Barcelona (Spain)
18:30 – 19:00 PIBD; the past leading to our present. Anne Griffiths, Toronto (Canada)
19:00 – 19:30 Future directions in IBD treatment. Julià Panés, Barcelona (Spain)
Thursday, 14th September
The scientific sessions on thursday morning are sponsored by SEGHNP
(Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica)
Chairs: Anne Griffiths, Toronto (Canada), Victor Manuel Navas-López, Málaga (Spain)
09:00 – 09:20 Predicting clinical course and variability in PIBD. Jeffrey Hyams, Connecticut (USA)
09:20 – 09:40 Have we learned how to manage the unsatisfactory response to anti-TNF? Marla Dubinsky, New York (USA)
09:40 – 10:00 Real evidence of new biologics in PIBD. Vedolizumab and Ustekinumab; how to use them in children Robert Baldassano, Philadephia (USA)
10:00 – 10:10 Q&A
10:10 – 10:20 Best Abstract. OP01. Intensified infliximab induction is associated with decreased colectomy rate in steroid-refractory pediatric ulcerative colitis. Peter Church1, Shaun Ho1, Ajay Sharm1, Karen Frost1, Joley Johnstone1, Aleixo Muise1,2, Thomas Walters1,2, Anne Griffiths1,2 1Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Canada, 2Inflammatory Bowel Disease Centre, The Hospital for Sick Children, Toronto, Canada.
10:20 – 10:30 Best Abstract. OP002. Contribution of individual PCDAI subscores to remission in pediatric patients with Crohn’s disease: results from IMAGINE 1 Trial. Jeffrey Hyams1, Frank Ruemmele2, Joel Rosh3, Dan Turner4, Marla Dubinsky5, Andreas Lazar6, Bidan Huang7, Joel Petersson7, Gabriela Alperovich8, Anne Robinson7 1Connecticut Children’s Medical Centre, Hartford, United States of America, 2Universite Sorbonne Paris-Cite, Hospital Necker-Enfants Malades, Paris, France, 3Goryeb Children’s Hospital/Atlantic Health, Morristown, United States of America, 4Shaare Zedek Medical Center, Jerusalem, Israel, 5Icahn School of Medicine at Mount Sinai, New York, United States of America, 6AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 7AbbVie, North Chicago, United States of America, 8AbbVie Spain S.L.U., Madrid, Spain.
Chair: Marla Dubinsky, New York (USA), Iñaki Irastorza, Bilbao (Spain)
11:00 – 11:20 VEOIBD – It is time to make the correct diagnosis. Aleixo Muise, Toronto (Canada)
11:20 – 11:40 Systemic diseases with intestinal involvement; not always IBD. David Wilson, Edinburgh (UK)
11:40 – 12:00 Intestinal inflammation in special cases with underlying conditions. Neil Shah, London (UK)
12:00 – 12:10 Q&A
12:10 – 12:20 Best Abstract. OP003. Whole exome sequencing of over 1000 pediatric IBD patients from a single center identifies monogenic forms of IBD. Eileen Crowley1, N Warner1, K Fiedler1, R Murchie1, PC Church1, TD Walters1, AM Griffiths1, AM Muise1,2 1Inflammatory Bowel Disease Center and Cell Biology Program, Division of Gastroenterology, Hepatology, and Nutrition, Hospital for Sick Children, Toronto, Canada, 2Institute of Medical Science and Department of Biochemistry, University of Toronto, Toronto, Canada.
12:20 – 12:30 Best Abstract. OP004. Cytomegalovirus reactivation complicating pediatric inflammatory bowel disease. Wael El-Matary1, Camelia Sefanovici1, Paul Van Caeseele1, Vini Deora1, Jeff McCurdy2 1University Of Manitoba, Winnipeg, Canada, 2University of Ottawa, Ottawa, Canada.
Chair: Dan Turner, Jerusalem (Israel)
Speakers: Jorge Amil Dias (Portugal), Richard Russell (UK), Erasmo Miele (Italy), Salvatore Oliva (Italy)
Chairs: Hankje Escher, Rotterdam (Netherlands), Javier Martín de Carpi, Barcelona (Spain)
14:45 – 15:05 PIBD; the patient’s perspective. Tanit Tubau, Barcelona (Spain)
15:05 – 15:25 PIBD: The European Union perspective. Grigorij Kogan, Brussels (Belgium)
15:25 – 15:45 Debate
15:45 – 15:55 Best Abstract. OP005. Telemonitoring versus usual care: a multicenter trial among teenagers with inflammatory bowel disease. Anke Heida1, Alie Dijkstra1, Anneke Muller Kobold1, Angelika Kindermann2, Freddy Kokke3, Tim de Meij4, Obbe Norbruis5, Margreet Wessels6, Thalia Hummel7, Hankje Escher8, Herbert van Wering9, Danielle Hendriks10, Luisa Mearin11, Henk Groen1, Henkjan Verkade1, Patrick van Rheenen1 1University Medical Center Groningen, Groningen, Netherlands, 2Emma Children’s Hospital Academic Medical Center, Amsterdam, The Netherlands, 3Wilhelmina Children’s Hospital, Utrecht, The Netherlands, 4VU Medical Center, Amsterdam, The Netherlands, 5ISALA clinic, Zwolle, The Netherlands, 6Rijnstate Hospital, Arnhem, The Netherlands, 7Medisch Spectrum Twente, Enschede, The Netherlands, 8Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, The Netherlands, 9Amphia Hospital, Breda, The Netherlands, 10Haga Hospital, The Hague, The Netherlands, 11Leiden University Medical Center, Leiden, The Netherlands.
15:55 – 16:05 Best Abstract. OP006. Childhood-onset inflammatory bowel disease and subsequent school performance – a population based cohort study. Petter Malmborg1,2, Natalia Mouratidou3, Michael C Sachs4, Martin Neovius5, Anders Hjern5,6, Karin E Smedby5, Anders Ekbom5, Johan Askling5, Jonas F Ludvigsson7,8,9,10, Ola Olén1,5,11 1Sachs’ Children Hospital, Stockholm, Sweden, 2Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden, 3Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden, 4Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 5Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 6Centre for Health Equity Studies, Stockholm University/Karolinska Institutet, Stockholm, Sweden, 7Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, 8Department of Pediatrics, Örebro University Hospital, Örebro, Sweden, 9Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom, 10Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA, 11Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
16:05 – 16:15 Best Abstract. OP007. Patient engagement in research: using the James Lind alliance process to identify the top 10 research questions in pediatric IBD. Anthony Otley1, Anne Griffiths2, Kate Murray6, Marie-Josee Trempe4, Muneet Maghera5, Malcolm Mann8, Cheryl Kluthe3, Melissa Mansi9, Melissa Crane7, Amanda Hood7, Andreas Laupacis10, Amy Grant7, on behalf of Canadian Children IBD Network: a joint partnership of CIHR and the CHILD Foundation11 1Dalhousie University, Halifax, Canada, 2SickKids, Toronto, Canada, 3Stollery Children’s Hospital, Edmonton, Canada, 4Montreal Children’s Hospital, Montreal, Canada, 5Layperson, Vancouver, Canada, 6Layperson, Toronto, Canada, 7IWK Health Centre, Halifax, Canada, 8Layperson, Chester, Canada, 9Layperson, Edmonton, Canada, 10Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Canada, 11CIDsCANN.
Chairs: Natalia Egea, Barcelona (Spain), Gemma Pujol, Barcelona (Spain)
09:00 – 09:20 Nutritional assessment and RDIs in P-IBD. Mireia Termes, Barcelona (Spain)
09:20 – 09:40 Evidence for the use of nutritional therapies. Rotem Sigall-Boneh, Tel Aviv (Israel)
09:40 – 10:00 Patient and family’s perspective on diet and its implications on disease management. Konstantinos Gerasimidis, Glasgow (UK)
10:00 – 10:15 Q&A
10:15 – 10:25 Best Abstract. NDOP01. Outcomes from patient pre visit planning (PVP) in Paediatric Inflammatory Bowel Disease (PIBD) using the Improve care now (ICN) tool. Sibongile Chadokufa1, Rachael Wearon1 1Great Ormond Street, London, United Kingdom.
10:25 – 10:35 Best Abstract. NDOP02. Qualitative study of children, adolescents and parents’ perspective after recent diagnosis with inflammatory bowel disease. Cheryl Kluthe1, Daniela Miglarese1, Kaitlynd Hiller2, Matthew Carroll1, Eytan Wine1, Michael van Manen2, Hien Huynh1 1EPIC, Department of pediatric, Stollery Children’s Hospital, University of Alberta, Edmonton, Canada, 2Department of pediatric, Stollery Children’s Hospital, University of Alberta, Edmonton, Canada.
Chairs: Ester Navarro, Barcelona (Spain), Laura Álvarez, Barcelona (Spain)
11:00 – 11:20 Dietetic and psychological adolescent support group. Dolores García-Arenas, Barcelona (Spain)
11:20 – 11:40 Nurse role in P-IBD. Mary Brennan, Cambridge (UK)
11:40 – 12:00 Psycho-social implications of the disease in children and adolescent’s lives. Laura Reigada, New York (USA)
12:00 – 12:15 Q&A
12:15 – 12:25 Best Abstract. NDOP03. The development of a nurse-led inflammatory bowel disease outpatient clinic: Meeting the needs of adolescents with inflammatory bowel disease. Sara Sider1, Sibongile Chadokufa, Rachael Wearon, Rhona Shepherd, Fevronia Kiparissi, Daniela Knafelz, Neil Shah, Aspasia Angelakopoulou 1Great Ormond Street Hospital, London, United Kingdom.
12:25 – 12:35 Best Abstract. NDOP04. Use of Exclusive Enteral Nutrition in Paediatric Crohn’s Disease in the Indian subcontinent. Lekha Sreedharan1, Dhanasekar Kesavelu1, Bhuvaneshwari Shankar1 1Apollo Childrens Hospital, Chennai, India.
Friday, 15th September
Chairs: Arie Levine, Tel Aviv (Israel), Eytan Wine, Edmonton (Canada)
09:00 – 09:20 Discovering the causes of PIBD: challenges and opportunities. Eytan Wine, Edmonton (Canada)
09:20 – 09:40 Early life events and microbiome: when does risk for IBD start? Joana Torres, Lisbon (Portugal)
09:40 – 10:00 Using omics to better understand the disease. Azucena Salas, Barcelona (Spain)
10:00 – 10:10 Q&A
10:10 – 10:20 Best Abstract. OP008. Transcriptional Analysis of Intestinal Epithelial Organoid Cultures Derived from Pediatric Crohn’s Disease Patients. Isabella Dotti1, Elena Ferrer-Picón1, Núria Planell2, Javier Martín de Carpi3, Gemma Pujol Muncunill3, M Carme Masamunt4, Julián Panés4, Azucena Salas1 1Experimental Gastroenterology Laboratory, IDIBAPS, Barcelona, Spain, 2Bioinformatics Platform, CIBERehd, Barcelona, Spain, 3Unit for Comprehensive Care of Pediatric Inflammatory Bowel Disease. Pediatric Gastroenterology, Hepatology and Nutrition Department. Hospital Sant Joan de Déu, Barcelona, Spain, 4Gastroenterology Department, Hospital Clínic, Barcelona, Spain.
10:20 – 10:30 Best Abstract. OP009. Stromal Cell – Innate Immune Cell Interactions in Pediatric Inflammatory Bowel Disease Patients. Egle Kvedaraite1, Magda Lourda2, Aline Van Acker1, David Unnersjö Jess3, Désirée Gavhed2, Jenny Mjösberg1, Maja Ideström4, Jan-Inge Henter2, Mattias Svensson1 1Center for Infectious Medicine, Karolinska Institute, Stockholm, Sweden, 2Childhood Cancer Research Unit, Karolinska Institute, Stockholm, Sweden, 3Science for Life Laboratory, Department of Applied Physics, Royal Institute of Technology, Stockholm, Sweden, 4Pediatric Gastroenterology, Hepatology and Nutrition Unit, Karolinska University Hospital, Stockholm, Sweden.
Chairs: Jeffrey Hyams, Connecticut (USA), Gemma Pujol, Barcelona (Spain)
11:00 – 11:20 What should be our main objective when treating our patients? Transmural vs mucosal healing. Marina Aloi, Roma (Italy)
11:20 – 11:40 Modulation of the microbiome as a therapy in IBD. Arie Levine, Tel Aviv (Israel)
11:40 – 12:00 Treatment of Crohn’s disease when medications aren’t working. Athos Bousvaros, Boston (USA)
12:00 – 12:10 Q&A
12:10 – 12:20 Best Abstract. OP010. Development and validation of the “mini index” (mucosal inflammation non-invasively index) for Crohn’s disease on a large prospective pediatric cohort. Assaf Ben Shoham1, Maarten A Cozijnsen2, Ben Kang3, Byung-Ho Choe3, Yon Ho Choe4, Richard K Russell5, Frank M Ruemmele6, Johana C Escher2, Lissy de Ridder2, Sibylle Koletzko7, Javier Martin de Carpi8, Jeffery Hyams9, Thomas D Walters10, Anne M Griffiths10, Dan Turner1 1Shaare Zedek Medical Center, Jerusalem, Israel, 2Erasmus MC/Sophia Children’s Hospital, Rotterdam, The Netherlands, 3Kyungpook National University School of Medicine , Daegu, Korea, 4Samsung Medical Center, , Korea, 5Royal Hospital for Children, Glasgow, UK, 6Université Paris Descartes – Sorbonne Paris Cité, APHP- Hôpital Necker Enfants Malades, Service de Gastroentérologie , Paris, France, 7Dr. von Hauner Children’s Hospital, LMU, Munich, Germany, 88Hospital Sant Joan de Déu, Barcelona, Spain, 9Connecticut Children’s Medical Center, Hartford, USA, 10Hospital for Sick Children, Toronto, Canada.
12:20 – 12:30 Best Abstract. OP011. Efficacy of Vedolizumab in Anti-TNF refractory Paediatric Ulcerative Colitis: Data from the Canadian Children Inflammatory bowel disease Network (CIDsCaNN). Nicholas Carman1, Eileen Crowley1, David Mack2, Hien Huynh4, Eytan Wine4, Wael El-Matery3, Amanda Ricciuto1, Valerie Arpino1, Peter Church1, Thomas Walters1, Anne Griffiths1 1The Hospital For Sick Children, Toronto, Canada, 2Children’s Hospital of Eastern Ontario, Ottawa, Canada, 3Winnipeg Children’s Hospital, Winnipeg, Canada, 4University of Alberta, Edmonton, Canada.
Chairs: Elena Ricart, Barcelona (Spain), Santiago Jiménez, Oviedo (Spain)
14:00 – 14:20 Adult gastroenterologist’s perspective. Give the disease a chance? Gert Van Assche, Leuven (Belgium)
14:20 – 14:40 Pediatric gastroenterologist’s perspective. Is it mandatory to prevent any kind of activity? Frank Ruemmele, Paris (France)
14:40 – 15:00 Discussion
Chairs: Laura Saura, Barcelona (Spain), Ruth García Romero, Zaragoza (Spain)
Speakers: Elena Ricart, Beatriz Martín, Jordi Rimola, Barcelona (Spain)
Chairs: David Wilson, Edinburgh (UK), Oscar Segarra, Barcelona (Spain)
16:00 – 16:20 Growth failure and bone health. Richard K Russell, Glasgow (UK)
16:20 – 16:40 Treatment of complex IBD in very young children. Judith Kelsen, Philadelphia (USA)
16:40 – 17:00 Psychological aspects. Laura Reigada, New York (USA)
17:00 – 17:20 Medications side-effects and how to manage them. Hankje Escher, Rotterdam (Netherlands)
17:20 – 17:40 Extra-intestinal manifestations and communication with other specialists. Gemma Pujol, Barcelona (Spain)
Saturday, 16th September
Chairs: Víctor Manuel Navas-López, Málaga (Spain), María Navalón, Murcia (Spain)
11:00 – 12:30 | Grand finale; Objectives for the future, prizes, announcements and much more!
Chairs: Dan Turner, Jerusalem (Israel), Javier Martín de Carpi (Spain)
11:00 – 12:00 Defining our priority objectives for the future
11:00 – 11:30 Diagnosis and treatment; the earliest, the most accurate. Dan Turner, Jerusalem (Israel)
11:30 – 12:00 Follow-up, support, network. Javier Martín de Carpi, Barcelona (Spain)
12:00 – 12:10 Poster prizes
12:10 – 12:20 PIBD 2019 Presentation
12:20 – 12:30 Closing remarks and wrap-up